Supplementary Table 6.
Variable | Discovery cohort (n = 634) |
---|---|
Age, y, mean ± SD | 64.0 ± 15.7 |
Male, n (%) | 369 (58.2) |
Race/ethnicity, n (%) | |
Hispanic | 177 (27.9) |
African American | 161 (25.4) |
White | 137 (21.6) |
Asian | 35 (5.5) |
Other | 124 (19.6) |
Comorbidities, n (%) | |
Hypertension | 229 (36.1) |
Diabetes mellitus | 141 (22.2) |
Obesity (BMI > 30)a | 211 (37.1) |
Chronic lung disease | 59 (9.3) |
Heart disease | 111 (17.5) |
Chronic kidney disease | 95 (15.0) |
Cancer | 66 (10.4) |
HIV | 11 (1.7) |
Inflammatory bowel disease | 7 (1.1) |
Disease severity, n (%) | |
Mild | 54 (8.5) |
Moderate | 361 (56.9) |
Severe | 158 (24.9) |
Severe with EOD | 61 (9.6) |
Outcomes, n (%) | |
ICU admission | 110 (17.4) |
Mortality | 151 (23.8) |
GI symptoms, n (%) | |
Nausea | 157 (24.8) |
Vomiting | 82 (12.9) |
Diarrhea | 245 (38.6) |
Any GI symptoms | 299 (47.2) |
SD, standard deviation.
BMI information was available for 568 of 634 patients.